Articles with "rivaroxaban combination" as a keyword



Photo by nci from unsplash

RIVAROXABAN IN COMBINATION WITH ANTIARRHYTHMIC DRUGS DOES NOT INCREASE THE BLEEDING RISKS IN PATIENTS WITH NON-PERMANENT ATRIAL FIBRILLATION

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of the American College of Cardiology"

DOI: 10.1016/s0735-1097(20)30957-8

Abstract: Rivaroxaban (RIVA) is useful for stroke prevention in atrial fibrillation (AF) patients. Antiarrhythmic drugs (AADs) prevent the recurrence of AF in non-permanent AF (npAF). There are limited data regarding drug-drug interactions between RIVA and AADs.… read more here.

Keywords: atrial fibrillation; non permanent; combination antiarrhythmic; rivaroxaban combination ... See more keywords